More tools:Markets·Screener·Research·Chat

Pro-Dex Inc New (PDEX) Financial Statements

Pro-Dex Inc New
SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
FIGI BBG001S6F1W9
XNAS · usd
66.41▼ 7.00 (-9.54%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close73.41
Day's Range66.25 – 73.95
52-Week Range23.47 – 77.00
Volume106.8K
Avg Volume74.2K
Share Statistics
Shares Outstanding
Employees181
ExchangeXNAS
Listed1986-08-07
Share count as of September 2, 2026
Loading Income Statement…
Key questions about Pro-Dex Inc New (PDEX)
What is Pro-Dex Inc New's Market Cap?
Pro-Dex Inc New's Market Cap is $212.7M, based on as-reported figures from SEC (XBRL) filings.
What is Pro-Dex Inc New's Enterprise Value?
Pro-Dex Inc New's Enterprise Value is $220.9M, based on as-reported figures from SEC (XBRL) filings.
What is Pro-Dex Inc New's Trailing P/E?
Pro-Dex Inc New's Trailing P/E is 15.6×, based on as-reported figures from SEC (XBRL) filings.
What is Pro-Dex Inc New's Price / Sales?
Pro-Dex Inc New's Price / Sales is 2.7×, based on as-reported figures from SEC (XBRL) filings.
What is Pro-Dex Inc New's EV / Revenue?
Pro-Dex Inc New's EV / Revenue is 2.8×, based on as-reported figures from SEC (XBRL) filings.
What is Pro-Dex Inc New's EV / EBITDA?
Pro-Dex Inc New's EV / EBITDA is 16.9×, based on as-reported figures from SEC (XBRL) filings.
What is Pro-Dex Inc New's Revenue (TTM)?
Pro-Dex Inc New's Revenue (TTM) is $77.5M, based on as-reported figures from SEC (XBRL) filings.
What is Pro-Dex Inc New's Net Income (TTM)?
Pro-Dex Inc New's Net Income (TTM) is $13.7M, based on as-reported figures from SEC (XBRL) filings.
What is Pro-Dex Inc New's EBITDA?
Pro-Dex Inc New's EBITDA is $14.4M, based on as-reported figures from SEC (XBRL) filings.
What is Pro-Dex Inc New's Diluted EPS (TTM)?
Pro-Dex Inc New's Diluted EPS (TTM) is 4.26, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Total net sales
YoY growth+16.6%+14.6%+11.1%+24.4%
Cost of Revenue
Gross profit
% of revenue34.8%30.7%30.8%29.0%
Operating expenses:
Selling, General and Administrative Expense
Research and Development Expense
Total operating expenses
% of revenue17.5%15.2%13.3%12.2%
Operating income
% of revenue17.3%15.5%17.5%16.8%
Other income (expense):
Interest and Dividend Income (Non-Bank)———
Gain/Loss on Investments—
Interest expense
Total other income——
Income Before Tax
Income tax expense
Net income
% of revenue14.0%19.7%11.7%25.3%
Earnings Per Share (Basic)
Earnings Per Share (Diluted)